Form 4 Tracker
Jason R Kelly

Director, CEO & Founder · 1 filing · Latest: Apr 7, 2026

Ginkgo Bioworks Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
DNA
Jason R KellyDirector, CEO & FounderApr 9, 2026
Sale
$6.40109,767$702.2K316,483
DNA
Jason R KellyDirector, CEO & FounderApr 8, 2026
Sale
$6.9397,015$672.3K426,250
DNA
Jason R KellyDirector, CEO & FounderApr 8, 2026
Option Exercise
212,949523,265
DNA
Jason R KellyDirector, CEO & FounderApr 7, 2026
Option Exercise
212,949310,316
DNA
Kelly Jason RApr 9, 2026
Proposed Sale
$6.40109,767$702.2K
DNA
Kelly Jason RApr 8, 2026
Proposed Sale
$6.9397,015$672.3K